Black Rock Inc. Krystal Biotech, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,947,845 shares of KRYS stock, worth $629 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,947,845

Previous 1,805,379 118.67%

Holding current value

$629 Million

Previous $321 Million 125.69%

% of portfolio

0.02%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$153.12 - $183.64 $328 Million - $393 Million	2,142,466 Added 118.67%	3,947,845 $725 Million
Q1 2024 May 10, 2024	SELL	$108.01 - $179.35 $450,185 - $747,530	-4,168 Reduced 0.23%	1,805,379 $321 Million
Q4 2023 Feb 13, 2024	BUY	$96.0 - $128.29 $10.3 Million - $13.8 Million	107,303 Added 6.3%	1,809,547 $224 Million
Q3 2023 Nov 13, 2023	BUY	$108.51 - $130.22 $7.48 Million - $8.98 Million	68,970 Added 4.22%	1,702,244 $197 Million
Q2 2023 Aug 11, 2023	SELL	$78.48 - $130.32 $6.5 Million - $10.8 Million	-82,821 Reduced 4.83%	1,633,274 $192 Million
Q1 2023 May 12, 2023	BUY	$72.39 - $84.27 $1.19 Million - $1.39 Million	16,499 Added 0.97%	1,716,095 $137 Million
Q4 2022 Feb 13, 2023	BUY	$63.14 - $79.9 $8.48 Million - $10.7 Million	134,291 Added 8.58%	1,699,596 $135 Million
Q3 2022 Nov 14, 2022	SELL	$64.85 - $82.4 $8.82 Million - $11.2 Million	-136,017 Reduced 7.99%	1,565,305 $109 Million
Q2 2022 Aug 12, 2022	BUY	$48.93 - $73.47 $871,492 - $1.31 Million	17,811 Added 1.06%	1,701,322 $112 Million
Q1 2022 May 12, 2022	BUY	$51.99 - $72.11 $4.06 Million - $5.63 Million	78,015 Added 4.86%	1,683,511 $112 Million
Q4 2021 Feb 10, 2022	BUY	$39.81 - $88.24 $2.55 Million - $5.66 Million	64,110 Added 4.16%	1,605,496 $112 Million
Q3 2021 Nov 09, 2021	BUY	$52.01 - $71.77 $470,170 - $648,800	9,040 Added 0.59%	1,541,386 $80.5 Million
Q2 2021 Aug 11, 2021	BUY	$62.14 - $81.82 $95.2 Million - $125 Million	1,532,346 New	1,532,346 $104 Million

Others Institutions Holding KRYS

# of Institutions

310

Shares Held

24.3M

Call Options Held

483K

Put Options Held

364K

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.09B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account